Pure Global AI
NCT06327542Not yet recruiting

Group-based Integrative Pain Management in Primary Care Safety Net Clinics

Group-based Integrative Pain Management: A Multi-level Approach to Address Intersectional Stigma and Social Isolation in Diverse Primary Care Safety Net Patients With Chronic Pain
University of California, San FranciscoClinicalTrials.govother
Verified
Study focus
Disease/Condition
Chronic Pain
Drug/Device/Intervention
Group Acupuncture
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of California, San Francisco
Location
San Francisco, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Apr 30, 2027
Enrollment
360 participants
Primary outcome

Change in pain impact measured as a composite score of pain intensity, pain interference, and physical function.,Change in Social support and Pain Questionnaire (SPQ)

Summary

Socioeconomically disadvantaged populations have a high prevalence of chronic pain,
 exacerbated by social isolation, intersectional stigma, and disparities in pain assessment
 and treatment options. Effective interventions using a multilevel, biopsychosocial approach
 are needed to decrease the unequal burden of pain. The proposed study will test group-based
 integrative models of pain management in primary care safety net clinics to improve pain care
 for racially and ethnically diverse low-income patients.

ICD-10 classifications
Other chronic painChronic intractable painPain, not elsewhere classifiedPain, unspecifiedPain associated with micturition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06327542
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06327542 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Francisco and is currently Not yet recruiting. The study focuses on Chronic Pain. Target enrollment is 360 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.